Suchergebnisse - Mabel Ryder

  • Treffer 1 - 19 von 19
Treffer weiter einschränken
  1. 1
    Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond

    Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond von Maria E. Cabanillas, Mabel Ryder, Camilo Jiménez

    Veröffentlicht 2019
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  2. 2
    PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients

    PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients von Anupam Kotwal, Lisa A. Kottschade, Mabel Ryder

    Veröffentlicht 2019
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution

    Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution von Mabel Ryder, Margaret K. Callahan, Michael A. Postow, Jedd D. Wolchok, James A. Fagin

    Veröffentlicht 2014
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells

    Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells von Matti L. Gild, Iñigo Landa, Mabel Ryder, Ronald Ghossein, Jeffrey A. Knauf, James A. Fagin

    Veröffentlicht 2013
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancer

    Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancer von Anupam Kotwal, Michael P. Gustafson, Svetlana Bornschlegl, Allan B. Dietz, Danae A. Delivanis, Mabel Ryder

    Veröffentlicht 2024
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Immune Checkpoint Inhibitor-Induced Thyroiditis Is Associated with Increased Intrathyroidal T Lymphocyte Subpopulations

    Immune Checkpoint Inhibitor-Induced Thyroiditis Is Associated with Increased Intrathyroidal T Lymphocyte Subpopulations von Anupam Kotwal, Michael P. Gustafson, Svetlana Bornschlegl, Lisa A. Kottschade, Danae A. Delivanis, Allan B. Dietz, Manish J. Gandhi, Mabel Ryder

    Veröffentlicht 2020
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression

    Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression von Mabel Ryder, Matti L. Gild, Tobias M. Hohl, Eric G. Pamer, Jeffrey A. Knauf, Ronald Ghossein, Johanna A. Joyce, James A. Fagin

    Veröffentlicht 2013
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms

    Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms von Danae A. Delivanis, Michael P. Gustafson, Svetlana Bornschlegl, Michele M. Merten, Lisa A. Kottschade, Sarah G. Withers, Allan B. Dietz, Mabel Ryder

    Veröffentlicht 2017
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Relief of Feedback Inhibition of <i>HER3</i> Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in <i>BRAF</i>-Mutant Thyroid Carcinomas

    Relief of Feedback Inhibition of <i>HER3</i> Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in <i>BRAF</i>-Mutant Thyroid Carcinomas von Cristina Montero‐Conde, Sergio Ruiz‐Llorente, José Miguel Domínguez, Jeffrey A. Knauf, Agnès Viale, Eric J. Sherman, Mabel Ryder, Ronald Ghossein, Neal Rosen, James A. Fagin

    Veröffentlicht 2013
    Volltext Volltext
    Carta
    Zu den Favoriten
    Gespeichert in:
  10. 10
    Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for<i>BRAF, PIK3CA</i>, and<i>AKT1</i>

    Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for<i>BRAF, PIK3CA</i>, and<i>AKT1</i> von Julio C. Ricarte‐Filho, Mabel Ryder, Dhananjay Chitale, Michael Rivera, Adriana Heguy, Marc Ladanyi, Manickam Janakiraman, David B. Solit, Jeffrey A. Knauf, R. Michael Tuttle, Ronald Ghossein, James A. Fagin

    Veröffentlicht 2009
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study

    Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study von Ashish V. Chintakuntlawar, Kandelaria M. Rumilla, Carin Y. Smith, Sarah M. Jenkins, Robert L. Foote, Jan L. Kasperbauer, John C. Morris, Mabel Ryder, Samer Alsidawi, Crystal Hilger, Keith C. Bible

    Veröffentlicht 2017
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

    Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy von Laura Boucai, Mahesh Saqcena, Fengshen Kuo, Ravinder K. Grewal, Nicholas D. Socci, Jeffrey A. Knauf, Gnana P. Krishnamoorthy, Mabel Ryder, Alan L. Ho, Ronald Ghossein, Luc G.T. Morris, Venkatraman Seshan, James A. Fagin

    Veröffentlicht 2023
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation

    Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation von Debyani Chakravarty, Elmer Santos, Mabel Ryder, Jeffrey A. Knauf, Xiao-Hui Liao, Brian L. West, Gideon Bollag, Richard Kolesnick, Tin Htwe Thin, Neal Rosen, Pat Zanzonico, Steven M. Larson, Samuel Refetoff, Ronald Ghossein, James A. Fagin

    Veröffentlicht 2011
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma

    Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma von Sara Bedrose, Kevin C. Miller, Lina Altameemi, M. Shaaban Ali, Sameh Nassar, Naveen Garg, Marilyne Daher, Keith D. Eaton, Jeffrey T. Yorio, Davey B. Daniel, Matthew T. Campbell, Keith C. Bible, Mabel Ryder, Ashish V. Chintakuntlawar, Mouhammed Amir Habra

    Veröffentlicht 2020
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer

    Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer von Naiyarat Prasongsook, Aditi Kumar, Ashish V. Chintakuntlawar, Robert L. Foote, Jan L. Kasperbauer, Julian R. Molina, Yolanda I. Garces, J. Daniel, Michelle A. Neben Wittich, Joseph Rubin, Ronald L. Richardson, John H. Morris, Ian Hay, Vahab Fatourechi, Bryan McIver, Mabel Ryder, Geoffrey B. Thompson, Clive S. Grant, Melanie L. Richards, Thomas J. Sebo, Michael Rivera, Vera J. Suman, Sarah M. Jenkins, Robert C. Smallridge, Keith C. Bible

    Veröffentlicht 2017
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

    Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology von John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano J. Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew J. Frigault, Brianna Hoffner, Christopher Hoimes, Mario E. Lacouture, Frederick L. Locke, Matthew A. Lunning, Nisha Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Momen M. Wahidi, Yinghong Wang, Alyse Johnson-Chilla, Jillian L. Scavone

    Veröffentlicht 2019
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  17. 17
    NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

    NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020 von John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano J. Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew J. Frigault, Benjamin H. Kaffenberger, Matthew A. Lunning, Suzanne McGettigan, Jordan P. McPherson, Nisha Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Nathan A. Pennell, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Yinghong Wang, Ryan Weight, Alyse Johnson-Chilla, Griselda Zuccarino-Catania, Anita M. Engh

    Veröffentlicht 2020
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment

    American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thy... von David C. Shonka, Alan L. Ho, Ashish V. Chintakuntlawar, J.L. Geiger, Jong Chul Park, Nagashree Seetharamu, Sina Jasim, Amr H. Abdelhamid Ahmed, Keith C. Bible, Marcia S. Brose, Maria E. Cabanillas, Kirsten F. A. A. Dabekaussen, Louise Davies, Dora Dias‐Santagata, James A. Fagin, William C. Faquin, Ronald Ghossein, Raj K. Gopal, Akira Miyauchi, Yuri E. Nikiforov, Matthew D. Ringel, Bruce Robinson, Mabel Ryder, Eric J. Sherman, Peter M. Sadow, Jennifer J. Shin, Brendan C. Stack, R. Michael Tuttle, Lori J. Wirth, Mark Zafereo, Gregory W. Randolph

    Veröffentlicht 2022
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  19. 19
    Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology

    Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology von John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Amaka Achufusi, Philippe Armand, Meghan Berkenstock, Shailender Bhatia, Lihua E. Budde, Saurin Chokshi, Marianne Davies, Amro Elshoury, Yaron Gesthalter, Aparna Hegde, Michael D. Jain, Benjamin H. Kaffenberger, Melissa G. Lechner, Tianhong Li, Alissa S. Marr, Suzanne McGettigan, Jordan P. McPherson, Theresa Medina, Nisha Mohindra, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Pradnya D. Patil, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Yinghong Wang, Vlad G. Zaha, Megan Lyons, Mary A. Dwyer, Lisa Hang

    Veröffentlicht 2022
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: